Fluorine-18-fluorodeoxyglucose uptake in pneumonia

Area of Science:

• Nuclear Medicine
• Oncology
• Pulmonology

Background:

• Whole-body 18F-fluorodeoxyglucose (FDG) PET imaging is a key tool for differentiating benign and malignant pulmonary lesions.
• Elevated FDG uptake, with standardized uptake values (SUVs) below 2.5, is typically associated with benign conditions like pneumonia.
• Accurate interpretation is crucial for patient management and avoiding unnecessary interventions.

Observation:

• A case study involving a patient with presumed bacterial pneumonia and a concurrent squamous cell carcinoma in the contralateral lung.
• Both the pneumonia and the squamous cell carcinoma exhibited markedly elevated FDG uptake.
• The standardized uptake values (SUVs) for both lesions were notably similar, recorded at 4.9 and 5.4.

Findings:

• Bacterial pneumonia can present with significantly high FDG uptake, similar to that of malignant lung lesions.
• This high uptake in inflammatory processes can lead to false-positive results in FDG PET imaging.
• The findings challenge the typical SUV threshold used to distinguish benign from malignant pulmonary abnormalities.

Implications:

• Inflammatory conditions, such as pneumonia, should be considered as potential causes of false-positive FDG PET findings in focal pulmonary abnormalities.
• Clinicians should exercise caution when interpreting elevated FDG uptake in the lungs, especially when clinical suspicion for infection is present.
• This case highlights the need for careful correlation with clinical and other imaging findings to avoid misdiagnosis.